David Kekich is a recognized personality for longevity science. In 1999, he founded “Maximum Life Foundation”, a 501(c)(3) not-for-profit corporation dedicated to reversing human aging and aging related diseases. David realized the inevitability that science will someday control the human aging process. He understood human beings will someday be able to enjoy open-ended health spans by studying aging, the root cause of most deadly diseases. The problem? He was in a race against the clock.
He was faced with the possibility of being part of the “last generation” to suffer and die from aging related diseases. His solution was to further aging research and move it forward by establishing Maximum Life Foundation.
Since then, the Foundation, in concert with many of the world’s leading researchers, has developed a scientific roadmap to transform the elderly to biological youth. He is active in companies with proprietary gene therapy, stem cell and other technologies which target longevity. David raises funds for life-extending research and served as a Board Member of several prominent industry organizations. The Foundation recently funded a human gene therapy study for Alzheimer’s disease.
He starred in two life extension documentaries and was featured in two others. David is a popular lecturer and spoke to thousands of people on the topic. He has appeared on numerous television and radio shows and on many webinars. He was also featured in newspaper and magazine articles and publishes a widely read newsletter, Longevity News Alert, and authored Smart, Strong and Sexy at 100.
David first became intrigued with extreme life extension in 1977 after founding the country’s largest life insurance master general agency, which raised $3.1 billion of premium income for First Executive Corp. This was where he was widely exposed to the realities of death from aging. He also arranged venture capital funding for private companies for eleven years. This was where he acquired the fundraising experience that he now directs toward biotech and other life-extending technologies.